Cary Guy Vance
CIK 1608992 · President and CEO · last filed 2026-06-01
Cary Guy Vance is a President and CEO who has filed 15 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing shows the insider was granted $15.3K of RCEL on Jun 1, 2026. Across all open-market trades the lifetime net is +$33.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $618.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HNSN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MOUNTAIN VIEW, CA 94043
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RCEL | President and CEO | 40,771 | $15.18 | $618.9K | $0 | 4 | 2026-06-01 |
| HANSEN MEDICAL INC (HNSN) Delisted | President and CEO | 15,492 | — | — | $33.4K | 10 | 2016-06-10 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-01 | RCEL | Grant (A) | +5,000 | $15.3K | EDGAR |
| 2025-06-05 | RCEL | Grant (A) | +10,022 | $0 | EDGAR |
| 2024-06-06 | RCEL | Grant (A) | +9,200 | $0 | EDGAR |
| 2023-06-08 | RCEL | Grant (A) | +16,549 | $0 | EDGAR |
| 2016-07-29 | — | Mixed | −15,492 | $0 | |
| 2016-06-10 | HANSEN MEDICAL INC (HNSN) Delisted | Sell (S) | −596 | -$2.4K | EDGAR |
| 2016-06-03 | HANSEN MEDICAL INC (HNSN) Delisted | Exer (M) | +1,491 | $0 | EDGAR |
| 2016-02-17 | HANSEN MEDICAL INC (HNSN) Delisted | Mixed | +7,097 | -$26.2K | EDGAR |
| 2016-02-04 | HANSEN MEDICAL INC (HNSN) Delisted | Mixed | +7,097 | -$26.2K | EDGAR |
| 2016-02-04 | HANSEN MEDICAL INC (HNSN) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.